Samsung C&T Engineering & Construction Group (hereafter Samsung C&T) is accelerating efforts to discover new growth engines by partnering with ...

Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced business updates and reported ...

Announced intent to separate biopharma operations from substantial royalty assets by YE 2026Phase 2 top-line data through Week 12 for rosnilimab, ...

Vertex Pharmaceuticals (VRTX) is rated as a "Strong Buy" due to robust revenue growth and multiple expansion opportunities ...

Led by General Catalyst, Lightspeed, and D1 Capital, Beacon is embedding leading AI and engineering talent into everyday industries that power million ...

In this Market Dialogues episode, experts discuss what’s driving efforts to connect private market data with public workflows ...

AI-driven precision-oncology analysis identifies patient subtypes with potential enhanced response to glufosfamide Accepted ASCO abstract, ...

Epicor has been recognized in the IDC MarketScape for worldwide AI-enabled large enterprise ERP applications 2025 vendor ...

Q3 2025 Earnings Call Transcript November 3, 2025 BioCryst Pharmaceuticals, Inc. misses on earnings expectations. Reported ...

Operator: Good morning, ladies and gentlemen, and welcome to the Cooper-Standard Third Quarter 2025 Earnings Conference Call.

The Hut 8 Corp. Third Quarter 2025 Conference Call will commence today, Tuesday, November 4, 2025, at 8:30 a.m. ET. Investors ...

Thanks to AI, data science tasks that once demanded specialized skills can now be performed faster, more accurately and at a ...